As part of our series focussing on medicines in Australia, we have added a product review of the use of bimekizumab for active psoriatic arthritis.
This review discusses indications and dosage, contraindications and a series of clinical studies featuring bimekizumab use to treat active psoriatic arthritis. It provides commentary from Associate Professor Andrew Östör, a Consultant Rheumatologist at Cabrini Medical Centre.
Please login below to download this issue (PDF)